Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Malondialdehyde is a small organic molecule classified as a β-dicarbonyl compound with the formula C₃H₄O₂. It is an endogenous product formed primarily during the peroxidation of polyunsaturated fatty acids in cells and foods. Malondialdehyde is highly reactive and exists mainly as its enol form under physiological conditions. It reacts readily with DNA and amino acids to form genotoxic adducts and protein crosslinks. This reactivity underlies its pathological significance; elevated levels are associated with cellular damage from oxidative stress in various diseases including cardiovascular disorders and neurodegeneration. Malondialdehyde itself is not considered a therapeutic target such as an enzyme or receptor but serves widely as a biomarker for lipid peroxidation and oxidative injury in clinical research settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Malondialdehyde (MDA).